Hygrovest Limited (HGV.AX)
AUD 0.05
(0.0%)
AUD 0.05
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -1.1 Million AUD | 46.58% |
| 2023 | -1.58 Million AUD | -8.37% |
| 2022 | -17.78 Million AUD | 9.72% |
| 2021 | -6.79 Million AUD | 1.22% |
| 2020 | -42.89 Million AUD | 39.91% |
| 2019 | 30.92 Million AUD | -107.91% |
| 2018 | 3.85 Million AUD | 410.23% |
| 2017 | -12.96 Million AUD | -70.79% |
| 2016 | -14.57 Million AUD | -9652.65% |
| 2015 | -66.54 Thousand AUD | 0.0% |
| 2014 | - AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -500.00 AUD | 99.99% |
| 2024 Q2 | -581 Thousand AUD | -116100.0% |
| 2024 FY | - AUD | 30.19% |
| 2024 Q4 | -522 Thousand AUD | 0.0% |
| 2023 FY | - AUD | -8.37% |
| 2023 Q3 | -2.63 Million AUD | -573.58% |
| 2023 Q2 | 556.5 Thousand AUD | 0.0% |
| 2023 Q1 | 556.5 Thousand AUD | 109.67% |
| 2023 Q4 | -2.63 Million AUD | 0.0% |
| 2022 FY | - AUD | 9.72% |
| 2022 Q4 | -5.75 Million AUD | 0.02% |
| 2022 Q3 | -5.75 Million AUD | -83.05% |
| 2022 Q1 | -3.14 Million AUD | -95.45% |
| 2022 Q2 | -3.14 Million AUD | 0.0% |
| 2021 Q3 | -1.6 Million AUD | -133.99% |
| 2021 FY | - AUD | 1.22% |
| 2021 Q4 | -1.6 Million AUD | -0.05% |
| 2021 Q1 | -1.78 Million AUD | -292.32% |
| 2021 Q2 | -687 Thousand AUD | 61.6% |
| 2020 Q2 | -1.17 Million AUD | 92.88% |
| 2020 Q4 | -456 Thousand AUD | 90.65% |
| 2020 FY | - AUD | 39.91% |
| 2020 Q3 | -4.87 Million AUD | -313.78% |
| 2020 Q1 | -16.56 Million AUD | -2301.16% |
| 2019 FY | - AUD | -107.91% |
| 2019 Q4 | -690 Thousand AUD | -103.44% |
| 2019 Q3 | 20.07 Million AUD | 541.4% |
| 2019 Q2 | -4.54 Million AUD | 0.0% |
| 2019 Q1 | -4.54 Million AUD | 29.7% |
| 2018 Q3 | -6.46 Million AUD | -19.95% |
| 2018 Q4 | -6.46 Million AUD | 0.0% |
| 2018 Q2 | -5.39 Million AUD | 0.0% |
| 2018 Q1 | -5.39 Million AUD | -86.71% |
| 2018 FY | - AUD | 410.23% |
| 2017 FY | - AUD | -70.79% |
| 2017 Q4 | -2.88 Million AUD | 0.0% |
| 2017 Q3 | -2.88 Million AUD | -45.99% |
| 2017 Q2 | -1.97 Million AUD | 0.0% |
| 2017 Q1 | -1.97 Million AUD | -50.28% |
| 2016 Q4 | -1.31 Million AUD | 0.0% |
| 2016 FY | - AUD | -9652.65% |
| 2016 Q2 | -1.86 Million AUD | 0.0% |
| 2016 Q3 | -1.31 Million AUD | 29.45% |
| 2016 Q1 | -1.86 Million AUD | 0.0% |
| 2015 Q1 | 653.00 AUD | 0.0% |
| 2015 Q2 | -38.65 Thousand AUD | -6019.3% |
| 2015 FY | - AUD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Althea Group Holdings Limited | -28.56 Million AUD | 96.138% |
| Cann Group Limited | -35.53 Million AUD | 96.896% |
| ECS Botanics Holdings Ltd | 3.22 Million AUD | 134.167% |
| Ecofibre Limited | -38.34 Million AUD | 97.123% |
| Elixinol Wellness Limited | -6.8 Million AUD | 83.794% |
| IDT Australia Limited | -5.13 Million AUD | 78.512% |
| Invion Limited | -4.57 Million AUD | 75.874% |
| Little Green Pharma Ltd | -4.64 Million AUD | 76.245% |
| Live Verdure Ltd | -12.51 Million AUD | 91.184% |
| Medical Developments International Limited | -29.44 Million AUD | 96.254% |
| Vitura Health Limited | 7.07 Million AUD | 115.587% |
| Vita Life Sciences Limited | 13.09 Million AUD | 108.421% |